Wells Fargo & Company Akoya Biosciences, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 8,507 shares of AKYA stock, worth $21,777. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,507
Previous 6,926
22.83%
Holding current value
$21,777
Previous $32,000
40.63%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AKYA
# of Institutions
59Shares Held
12.3MCall Options Held
67.9KPut Options Held
0-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$12 Million10.69% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$3.84 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.46MShares$3.75 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA562KShares$1.44 Million0.0% of portfolio
-
Svb Wealth LLC Boston, MA515KShares$1.32 Million0.03% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $97M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...